Similar articles

• A risk for hepatocellular carcinoma persists long-term after sustained virologic response in patients with hepatitis C-associated liver cirrhosis.

  Aleman S, Rahbin N, Weiland O, Davidsdottir L, Hedenstierna M, Rose N, Verbaan H, Stål P, Carlsson T, Norrgren H, Ekbom A, Granath F, Hultcrantz R. Aleman S, et al. Clin Infect Dis. 2013 Jul;57(2):230-6. doi: 10.1093/cid/cit234. Epub 2013 Apr 24. Clin Infect Dis. 2013. PMID: 23616492
• Effects of a sustained virologic response on outcomes of patients with chronic hepatitis C.

  Ng V, Saab S. Ng V, et al. Clin Gastroenterol Hepatol. 2011 Nov;9(11):923-30. doi: 10.1016/j.cgh.2011.05.028. Epub 2011 Jun 13. Clin Gastroenterol Hepatol. 2011. PMID: 21699815 Review.
• Long-term effect of sustained virological response on hepatocellular carcinoma in patients with hepatitis C in Canada.

  Janjua NZ, Chong M, Kuo M, Woods R, Wong J, Yoshida EM, Sherman M, Butt ZA, Samji H, Cook D, Yu A, Alvarez M, Tyndall M, Krajden M. Janjua NZ, et al. J Hepatol. 2017 Mar;66(3):504-513. doi: 10.1016/j.jhep.2016.10.028. Epub 2016 Nov 4. J Hepatol. 2017. PMID: 27818234
• Differences in background characteristics of patients with chronic hepatitis C who achieved sustained virologic response with interferon-free versus interferon-based therapy and the risk of developing hepatocellular carcinoma after eradication of hepatitis C virus in Japan.

  Toyoda H, Tada T, Takaguchi K, Senoh T, Shimada N, Hiraoka A, Michitaka K, Ishikawa T, Kumada T. Toyoda H, et al. J Viral Hepat. 2017 Jun;24(6):472-476. doi: 10.1111/jvh.12665. Epub 2017 Jan 11. J Viral Hepat. 2017. PMID: 27983762
• Sustained virologic response to antiviral therapy for chronic hepatitis C virus infection: a cure and so much more.

  Pearlman BL, Traub N. Pearlman BL, et al. Clin Infect Dis. 2011 Apr 1;52(7):889-900. doi: 10.1093/cid/cir076. Clin Infect Dis. 2011. PMID: 21427396 Review.